Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GDAP1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | BAHCC1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | ZNF22 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
mRNA | RPL26L1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | CDON | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | SCRT2 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
mRNA | ANKRD46 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | NEUROG3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | ARHGAP28 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | YEATS2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |